(Q39376321)

English

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

H H Tsai

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

R Chapman

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A Shepherd

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

D McKeith

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

M Anderson

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

D Vearer

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S Duggan

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

J P Rosen

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

COMMAND Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

657-665

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Review article: management of mild and severe gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02155.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.02155.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39376321&oldid=1823538427"